Slava Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 15-12-2024
- Paid Up Capital ₹ 0.10 M
as on 15-12-2024
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 5.23 Cr
as on 15-12-2024
- Revenue 137.51%
(FY 2020)
- Profit 163.11%
(FY 2020)
- Ebitda 165.80%
(FY 2020)
- Net Worth 184.33%
(FY 2020)
- Total Assets 329.31%
(FY 2020)
About Slava Therapeutics
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.23 Cr.
Mohana Gopinath and Sirisha Pilla serve as directors at the Company.
- CIN/LLPIN
U24304TG2017PTC118116
- Company No.
118116
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jul 2017
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Slava Therapeutics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohana Gopinath  | Director | 13-Nov-2020 | Current |
| Sirisha Pilla | Director | 06-Jul-2017 | Current |
Financial Performance of Slava Therapeutics.
Slava Therapeutics Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 137.51% increase. The company also saw a substantial improvement in profitability, with a 163.11% increase in profit. The company's net worth Soared by an impressive increase of 184.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Slava Therapeutics?
In 2020, Slava Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Antler Life Sciences Private LimitedActive 5 years 10 months
Mohana Gopinath and Sirisha Pilla are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 21 Nov 2020 | ₹3.25 M | Open |
Others Creation Date: 21 Mar 2020 | ₹4.90 Cr | Open |
How Many Employees Work at Slava Therapeutics?
Unlock and access historical data on people associated with Slava Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Slava Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Slava Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
